US Patent Issued to BEIJING TIDE PHARMACEUTICAL on July 28 for "2,4,6-tri-substituted pyrimidine compounds as ATR kinase inhibitors" (Chinese Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,257, issued on July 28, was assigned to BEIJING TIDE PHARMACEUTICAL Co. LTD. (Beijing).

"2,4,6-tri-substituted pyrimidine compounds as ATR kinase inhibitors" was invented by Yanping Zhao (Beijing), Bin Liu (Beijing), Yuanyuan Jiang (Beijing), Weiting Zhong (Beijing), Huifen Xu (Beijing), Hongjun Wang (Beijing), Li Mao (Beijing), Jingtao Li (Beijing), Honglei Zhang (Beijing), Chuangchuang Huang (Beijing), Jing Li (Beijing), Jing Zhao (Beijing), Weina Liu (Beijing), Nana Tian (Beijing), Liying Zhou (Beijing) and Yanan Liu (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are compounds represented by general formula (I), which can be use...